Related Experiment Video
Updated: Apr 6, 2026
08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
17.1K
Quantitative Analysis of Differential Proteome Expression in Bladder Cancer vs. Normal Bladder Cells Using SILAC
Ganglong Yang1, Zhipeng Xu2, Wei Lu1
1The Key Laboratory of Carbohydrate Chemistry & Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China.
Plos One
|August 1, 2015
Summary
Identifying bladder cancer progression markers is key for survival. This study quantitatively analyzed proteomes of normal, nonmuscle-invasive, and metastatic bladder cancer cell lines, revealing key protein differences.
Area of Science:
- Proteomics
- Cancer Biology
- Biochemistry
Background:
- Bladder cancer (BC) progression from nonmuscle-invasive to metastatic disease necessitates early identification for aggressive treatment.
- Standard BC cell line models (HCV29, KK47, YTS1) are crucial for studying molecular mechanisms, but comprehensive proteome analysis is lacking.
Purpose of the Study:
- To perform global quantitative proteome analysis on normal bladder epithelial and bladder cancer cell lines representing different disease stages.
- To identify differentially expressed proteins associated with bladder cancer progression using advanced mass spectrometry techniques.
Main Methods:
- Stable Isotope Labeling by Amino acids in Cell culture (SILAC) was employed for quantitative proteomic analysis.
- High-resolution liquid chromatography coupled with LTQ Orbitrap mass spectrometry was used for protein identification and quantification.
- Differential protein expression was validated using Western blotting, qRT-PCR, and immunohistochemistry.
Main Results:
- Over 3700 unique proteins were identified and quantified in the KK47 (low-grade NMIBC) and YTS1 (metastatic BC) cell lines.
- 36 proteins were significantly upregulated and 74 were significantly downregulated in metastatic versus low-grade NMIBC cells.
- Pathway analysis revealed involvement of differentially expressed proteins in DNA replication, molecular transport, cell growth, proliferation, migration, and survival.
Conclusions:
- This quantitative proteomic study provides a valuable resource for understanding molecular mechanisms driving bladder cancer progression.
- Identified proteins and methodologies can aid in developing biomarkers for early detection of aggressive bladder cancer.
- The findings support targeted therapeutic strategies for patients with muscle-invasive or metastatic bladder cancer.
